In addition, Saito and colleagues [34] reported using flow cytometric analysis that metformin treatment significantly reduces the number of tumor-initiating epithelial cell adhesion molecule (EpCAM)-positive HCC cells, which are considered as hepatic cancer stem cells. The gene discussed is EPCAM; the disease is liver neoplasm.